Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
November 11, 2021 08:30 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021
November 08, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical Presents Triferic® Real World Evidence Update at ASN Kidney Week 2021
November 04, 2021 16:01 ET
|
Rockwell Medical, Inc.
-Results from pilot observational analysis demonstrate maintenance of hemoglobin and reduction of total IV iron requirement in adult patients on Triferic receiving chronic hemodialysis- -Findings...
Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 09:52 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
August 19, 2021 16:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update
August 16, 2021 16:09 ET
|
Rockwell Medical, Inc.
-Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic® in Turkey- -Extended multi-year distribution agreement with Nipro Medical for dialysis...
Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021
July 29, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., July 29, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
June 28, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., June 28, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates
June 11, 2021 12:20 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., June 11, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey
June 08, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich. and ANKARA, Turkey, June 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and...